BridgeMD
Selective laser trabeculoplasty versus eye drops for first line treatment of exfoliation ocular hypertension or glaucoma: a randomised clinical trial
EU CTIS ID: 2024-520083-33-00
What this study is testing
The main objective of the trial is to show the equilance in efficacy of SLT laser treatment compared to medical therapy as a primary therapy in exfoliation glaucoma.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Informed consent
- Age of 50 –100 years
- Possibility to attend 12 months of period
- Exfoliation
- Newly diagnosed exfoliation glaucoma by EGS (European glaucoma society) guidelines or ocular hypertensio TA 24 mmHg or more
- Eye pressure less than 35 mmHg
You likely can't join if
- Advanced glaucoma
- Serious other medical condition preventing participation in the trial
- Participating in other clinical trial
- Target IOP less than 15
- Starting eye pressure 35 or more
- Visual acuity 0.2 or worse
See the full eligibility criteria
- Informed consent
- Age of 50 –100 years
- Possibility to attend 12 months of period
- Exfoliation
- Newly diagnosed exfoliation glaucoma by EGS (European glaucoma society) guidelines or ocular hypertensio TA 24 mmHg or more
- Eye pressure less than 35 mmHg
- Advanced glaucoma
- Serious other medical condition preventing participation in the trial
- Participating in other clinical trial
- Target IOP less than 15
- Starting eye pressure 35 or more
- Visual acuity 0.2 or worse
- Angle closure
- Unable to use eye drops
- Significant cataract
- Other active eye disease (active uveitis, clinical significant macular edema, wet AMD, proliferative diabetic retinopathy, intraocular tumor, intraocular injections, IOL luxation)
- Previous intraocular operation excluding uncomplicated cataracta surgery 1 year ago or earlier
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.